POMC and Cushing syndrome: Preoperative mifepristone treatment may shorten the posttreatment glucocorticoid replacement period in ACTH-independent Cushing syndrome, as evidenced by effective cortisol secretion neutralization without adrenal atrophy or postoperative glucocorticoid replacement requirement.